Indications and Purposes
| 1 Indications And Usage Taltz ® Is A Humanized Interleukin-17a Antagonist Indicated For The Treatment Of: Patients Aged 6 Years Or Older With Moderate-To-Severe Plaque Psoriasis Who Are Candidates For Systemic Therapy Or Phototherapy. ( 1.1 ) Adults With Active Psoriatic Arthritis. ( 1.2 ) Adults With Active Ankylosing Spondylitis. ( 1.3 ) Adults With Active Non-Radiographic Axial Spondyloarthritis With Objective Signs Of Inflammation. ( 1.4 ) 1.1 Plaque Psoriasis Taltz ® Is Indicated For The Treatment Of Patients 6 Years Of Age And Older With Moderate-To-Severe Plaque Psoriasis Who Are Candidates For Systemic Therapy Or Phototherapy. 1.2 Psoriatic Arthritis Taltz Is Indicated For The Treatment Of Adult Patients With Active Psoriatic Arthritis. 1.3 Ankylosing Spondylitis Taltz Is Indicated For The Treatment Of Adult Patients With Active Ankylosing Spondylitis. 1.4 Non-Radiographic Axial Spondyloarthritis Taltz Is Indicated For The Treatment Of Adult Patients With Active Non-Radiographic Axial Spondyloarthritis (Nr-Axspa) With Objective Signs Of Inflammation. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Ixekizumab |